טוען...
Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
The main psychedelic component of magic mushrooms is psilocybin, which shows promise as a treatment for depression and other mental disorders. Psychedelic effects are believed to emerge through stimulation of serotonin 2A receptors (5-HT2ARs) by psilocybin’s active metabolite, psilocin. We here repo...
שמור ב:
| הוצא לאור ב: | Neuropsychopharmacology |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer International Publishing
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6785028/ https://ncbi.nlm.nih.gov/pubmed/30685771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41386-019-0324-9 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|